Efficacy of a soy rich diet in preventing postmenopausal osteoporosis: The Menfis randomized trial

Maturitas

Volumn 42, Issue 4, 2002, Pages 295-300

  Chiechi, L M ^a   Secreto, G ^b   D'Amore, M ^a   Fanelli, M ^a   Venturelli, E ^b   Cantatore, F ^a   Valerio, T ^a   Laselva, G ^a   Loizzi, P ^a  

^a UNIVERSITY OF BARI   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Isoflavones; Menopause; Osteoporosis; Prevention; Soy

Indexed keywords

DAIDZEIN; HYDROXYPROLINE; OSTEOCALCIN;

ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; EVALUATION; FEMALE; HUMAN; OSTEOPOROSIS; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; REDUCTION; RISK FACTOR; TYPES OF STUDY;

ADULT; BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; COLLAGEN; COLLAGEN TYPE I; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, NON-STEROIDAL; FEMALE; HUMANS; HYDROXYPROLINE; ISOFLAVONES; MIDDLE AGED; OSTEOCALCIN; OSTEOPOROSIS, POSTMENOPAUSAL; PEPTIDES; PHYTOESTROGENS; PHYTOTHERAPY; PLANT PREPARATIONS; SOYBEANS;

STAPHYLOCOCCUS PHAGE 187;

EID: 0037199719     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(02)00158-5     Document Type: Article

References (30)

1. Pathogenesis of osteoporosis
2. The menopause and the skeleton: Key issues
3. Long term prevention of postmenopausal osteoporosis by oestrogen: Evidence for an increased bone mass after delayed onset of oestrogen treatment
4. Hip fracture and the use of estrogens in postmenopausal women. The Framingham study
5. Bone response to termination of oestrogen treatment
6. Treatment of osteoporosis in elderly women
7. The effect of postmenopausal estrogen therapy on bone density in elderly women
8. Cardiovascular risk and use of estrogens or estrogen-progestagen combinations. Stanford three-community study
9. A report from the Boston Collaborative Drug Surveillance Program
10. Breast cancer and hormone replacement therapy; Collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer
11. Long term consequences of estrogen and estrogen-progestinreplacement
12. Soy protein and isoflavones: Their efects on blood lipids and bone density in postmenopausal women
13. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenoapusal women
14. Effect of soy protein on bone metabolism in postmenopausal Japanese women
15. Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women
16. Soy isoflavones supplementation in postmenopausal women. Effects on plasma lipids, antioxidant enzyme activities and bone density
17. The effects of a soy rich diet on serum lipids: The Menfis randomized trial
18. Expression and localization of estrogen receptor β in murine and humane bone
19. Demonstration of estrogen receptor β immunoreactivity in human growth plate cartilage
20. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β
21. Novel aspects of estrogen action
22. Isoflavones and postmenopausal bone health: A viable alternative to estrogen to estrogen therapy?
23. Ipriflavone prevents the mass reduction in premenopausal women treated with gonadotropin hormone-releasing hormone agonists
24. Effect of ipriflavone on osteoporosis induced by ovariectomy in rats
25. Effect of ipriflavone on glucocorticoid-induced osteoporosis in rats
26. Treatment of bone loss in oophorectomized women with a combination of ipriflavone and conjugated equine estrogen
27. Role of soy protein with normal or reduced isoflavones content in reversing bone loss induced by ovarian hormone deficiency in rats
28. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis
29. Evaluation of the effect of soybean milk and soybean peptide on bone metabolism in the rat model with ovariectomized osteoporosis
30. Soyfoods, soybean isoflavones, and bone health: A brief overview